Galapagos NV
$28.01
24H
Market Cap
Volume
Supply
Price Chart
About Galapagos NV - GLPG.AS
Galapagos NV is a biotechnology company that specializes in the discovery and development of small molecule medicines with novel modes of action, aiming to address unmet medical needs. The company's headquarters are located in Mechelen, Belgium, with additional operations across Europe and the United States.
What are Galapagos NV's core values and mission statement?
Galapagos NV's core values are centered around innovation, collaboration, and commitment to patient care, with a mission to discover and develop novel medicines that will improve people's lives. They focus on harnessing scientific advancements to create transformative therapies for diseases with significant unmet medical needs.
Who founded Galapagos NV and when?
Galapagos NV was founded by Onno van de Stolpe in 1999.
Who leads Galapagos NV?
As of the time of your inquiry, Onno van de Stolpe is the founder and CEO of Galapagos NV.
Where is Galapagos NV located, and what is its base country?
Galapagos NV is headquartered in Mechelen, Belgium, and Belgium is its base country.
On which exchanges is Galapagos NV traded?
Galapagos NV is traded on the Euronext Amsterdam and Brussels under the ticker symbol GLPG, and on the NASDAQ Global Select Market in the United States under the ticker symbol GLPG.
Historical data
Galapagos NV (GLPG) Price Live Data
The live price of Galapagos NV (GLPG) is $28.01, with a trading volume of 112,312 in the last 24 hours. Wrapstocks updates the GLPG price in real-time. Galapagos NV is down -2.06% in the last 24 hours. The company has a live market cap of $1,875,710,079.85 and a supply of 66,966,198 GLPG stocks.
Galapagos NV (GLPG) is traded on Euronext Amsterdam Stock Exchange, and currently, the market is closed; trading will be resumed in 1 hour and 2 minutes.
